GlassScriptPhysician profile
Cheryl A Serr
NPI 1831199744
$2,940.56
in general payments reported to CMS, 2019-2025
29 companies · $50.31 in 2025
The $50.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $197 · 2021: $949 · 2022: $840 · 2023: $332 · 2024: $173 · 2025: $50.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.45 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,108.21 | 2019-2024 | Ubrelvy |
| Daiichi Sankyo INC. | $336.00 | 2020-2022 | |
| Myovant Sciences INC. | $193.07 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $163.91 | 2019 | |
| Pfizer INC. | $145.56 | 2022-2024 | |
| Therapeuticsmd, INC. | $133.57 | 2019-2021 | |
| Organon LLC | $99.92 | 2021-2023 | Nexplanon |
| Sumitomo Pharma America, INC. | $92.15 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $87.46 | 2023-2024 | Veozah |
| Alydia Health | $59.46 | 2021 | |
| Roche Diagnostics Corporation | $54.34 | 2020-2021 | |
| Coopersurgical, INC. | $53.31 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $50.31 | 2025 | |
| Merck Sharp & Dohme LLC | $42.59 | 2019-2021 | |
| Exact Sciences Corporation | $38.73 | 2023-2024 | Cologuard Collection Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $32.44 | 2021-2023 | Aptima |
| Lilly USA, LLC | $29.96 | 2019-2020 | |
| Allergan, INC. | $27.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.31 | 2022 | |
| Ferring Pharmaceuticals INC. | $21.00 | 2019 | |
| Becton, Dickinson and Company | $20.87 | 2023 | Bd Onclarity |
| Avanos Medical | $20.69 | 2022 | |
| Baudax Bio INC. | $17.92 | 2021 | |
| Evofem Biosciences, INC. | $16.61 | 2021 | |
| Baxter Healthcare | $16.06 | 2023 | Seprafilm |
| Medicem INC. | $14.26 | 2020 | |
| Medtronic, INC. | $13.87 | 2024 | V-Loc 180 |
| Minerva Surgical, INC | $13.46 | 2020 | |
| Aspira Women'S Health INC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Serr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.